Michal Gilon Ohev Zion
Chief Tech/Sci/R&D Officer at BioCancell Therapeutics, Inc.
Network origin in Michal Gilon Ohev Zion first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel.
9
| Subsidiary | Biotechnology | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michal Gilon Ohev Zion via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BANK HAPOALIM B.M. | Major Banks | Corporate Officer/Principal | |
Arison Investments Ltd.
 Arison Investments Ltd. Financial ConglomeratesFinance Arison Investments Ltd. provides investment services. The company was founded by Ted Arison in 1991 and is headquartered in Tel Aviv, Isreal. | Financial Conglomerates | Portfolio Manager-Equities | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Biotechnology | Director/Board Member | |
| CLS HOLDINGS PLC | Real Estate Development | Director/Board Member | |
| MENORA MIVTACHIM HOLDINGS LTD | Multi-Line Insurance | Director/Board Member | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Biomedical Instruments Divison of Lionheart Tech, Inc.
 Biomedical Instruments Divison of Lionheart Tech, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Fortive Corp., Biomedical Instruments Division of Lionheart Tech, Inc. is a company based in Carson City, NV. Biomedical Instruments Division of Lionheart Tech, Inc. develops, markets, and manufactures quality assurance instrumentation, software and systems, and clinical training tools for hospital bioengineering departments. The company was acquired by Fluke Corp. from Lionheart Technologies LLC on April 12, 2002 for $25 million. | Electronic Equipment/Instruments | Corporate Officer/Principal | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree Masters Business Admin Graduate Degree Graduate Degree Graduate Degree Masters Business Admin | |
| UNIVO PHARMACEUTICALS LTD | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
ColBar LifeScience Ltd.
 ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology ColBar LifeSciences Ltd. develops technology for tissue regeneration and tissue engineering. It manufactures and commercializes bio surgical products for applications in reconstructive medicine and tissue engineering. Its main focus is on the repair of damaged tissue in the human body like soft tissue, bone and skin. The company was founded in 1995 and is headquartered in Herzliya, Israel. | Medical Specialties | Director/Board Member | |
| Bar-Ilan University | College/University | Undergraduate Degree | |
| Bank of Israel | General Government | Director/Board Member | |
| APOSENSE LTD | Pharmaceuticals: Major | Director/Board Member | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Director/Board Member | |
| PLASTO-CARGAL GROUP LTD | Containers/Packaging | Director/Board Member | |
| MEDIWOUND LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Biokine Therapeutics Ltd.
 Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Clal Life Sciences (CLS) LP
 Clal Life Sciences (CLS) LP Investment ManagersFinance Part of Clal Biotechnology Industries Ltd., Clal Life Sciences (CLS) LP is a venture capital fund. | Investment Managers | Director/Board Member | |
ARTE Venture Group Ltd.
 ARTE Venture Group Ltd. Investment ManagersFinance Part of Clal Biotechnology Industries Ltd., ARTE Venture Group Ltd. is an alternative investment manager. The company is based in Ramat Gan, Israel. ARTE Venture Group was founded in 2003. | Investment Managers | Corporate Officer/Principal | |
Biomedical Investments
 Biomedical Investments Investment ManagersFinance Biomedical Investments operates as a private investment company. It focuses its investments on start-ups with breakthrough technologies, applicable in emerging therapeutic segments. The company was founded in 1997 and is headquartered in Tel-Aviv, Israel. | Investment Managers | Chief Executive Officer | |
Braintact Ltd.
 Braintact Ltd. Pharmaceuticals: MajorHealth Technology Braintact Ltd. engages in the development of neurodegenerative disorder drugs. The company was founded by Gadi Lipiner and is headquartered in Kiryat Shmona, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Clal Biotechnology Industries Ltd. (Venture Capital)
 Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Investment Managers | Chief Executive Officer President | |
Campus Bio Management Ltd.
 Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Avraham Pharmaceuticals Ltd.
 Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel. | Biotechnology | Director/Board Member Director/Board Member | |
| A. Heifetz & Co. | Chief Investment Officer | ||
| Israel Direct Insurance Ltd. | Chief Executive Officer | ||
| Campus Bio LLP | Director/Board Member | ||
Gili Medical Ltd.
 Gili Medical Ltd. Medical SpecialtiesHealth Technology Gili Medical Ltd. develops a device for continuous measurement of physiological parameters such as peripheral blood flow, blood pressure changes, environment, and skin temperature of the diabetic patients. The company was founded by Amir Schechter on July 21, 2010 and is headquartered in Kfar Saba, Israel. | Medical Specialties | Director/Board Member | |
| Provident Fund of the Hebrew University of Jerusalem Ltd. | Investment Managers | Chief Executive Officer | |
MinInvasive Ltd.
 MinInvasive Ltd. Medical SpecialtiesHealth Technology MinInvasive Ltd. develops arthroscopic device for rotator cuff repair in the shoulder. It manufactures Arthroscopic Trans Osseous Suture Passer for multiple applications in arthroscopic surgery. The company was founded in 2011 by Ziv Tamir and Moti Sholev and is headquartered in Magal, Israel. | Medical Specialties | Chairman | |
| CLAL Application Center Ltd. | Chairman | ||
Pi-Cardia Ltd.
 Pi-Cardia Ltd. Medical SpecialtiesHealth Technology Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel. | Medical Specialties | Chairman | |
Colospan Ltd.
 Colospan Ltd. Medical SpecialtiesHealth Technology Colospan Ltd. operates as a clinical stage and medical device company that develops a technology for colorectal surgery to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas. The company was founded by Boaz Assaf in December 2010 and is headquartered in Kfar Saba, Israel. | Medical Specialties | Director/Board Member | |
S.D. Sight Diagnostics Ltd.
 S.D. Sight Diagnostics Ltd. Medical SpecialtiesHealth Technology S.D. Sight Diagnostics Ltd. develops medical devices for diagnosing blood diseases. Its product, the Parasight platform, is the automated microscopy device for Malaria diagnosis. The company was founded by Joseph Joel Pollak in 2011 and is headquartered in Tel Aviv, Israel. | Medical Specialties | Director/Board Member | |
| Center Ltd. | Director/Board Member | ||
FDNA, Inc.
 FDNA, Inc. Packaged SoftwareTechnology Services FDNA, Inc. develops phenotype applications. The private company is based in Boston, MA. | Packaged Software | Director/Board Member | |
| HOLMES PLACE INTERNATIONAL LTD | Other Consumer Services | Director/Board Member | |
Anatomy Medical Technology Fund
 Anatomy Medical Technology Fund Investment ManagersFinance Anatomy Medical Technology Fund invests in companies located in Israel. The fund targets companies operating in the fields of medical technology. It provides financing for seed and early stage capital requirements. | Investment Managers | Corporate Officer/Principal Director/Board Member | |
Barcode Diagnostics Ltd.
 Barcode Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Barcode Diagnostics Ltd. is engaged in developing a product that assesses the efficacy of different cancer drugs directly on the tumor within the body to select the optimal personalized treatment for each patient. The company was founded by Ronen Eavri, Annie Sabbah, and Avi Schroeder in February 2017 and is headquartered in Nazareth, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Gamida Cell, Inc.
 Gamida Cell, Inc. BiotechnologyHealth Technology Part of Gamida Cell Ltd., Gamida Cell, Inc. develops cellular and immune therapeutics. The company is based in Medfield, MA. The CEO of the company is Julian Adams. | Biotechnology | Director/Board Member | |
| CACTUS ACQUISITION CORP. 1 LIMITED | Financial Conglomerates | Chief Executive Officer |
Statistics
International
| Israel | 41 |
| United States | 9 |
| United Kingdom | 2 |
| Turkey | 2 |
Sectoral
| Health Technology | 26 |
| Finance | 13 |
| Consumer Services | 5 |
| Electronic Technology | 2 |
| Government | 2 |
Operational
| Director/Board Member | 72 |
| Chairman | 17 |
| Corporate Officer/Principal | 15 |
| Chief Executive Officer | 9 |
| Independent Dir/Board Member | 8 |
Most connected contacts
| Insiders | |
|---|---|
| Ofer Gonen | 31 |
| Aharon Schwartz | 29 |
| Ofer Goldberg | 23 |
| Orly Yarkoni | 13 |
| Jonathan Burgin | 9 |
| Hanoch Rappaport | 8 |
| Monique Ben-Am | 4 |
| Avraham Hochberg | 3 |
| Avraham Hampel | 3 |
- Stock Market
- Insiders
- Michal Gilon Ohev Zion
- Company connections
